New Delhi | January 23, 2026: Akums Drugs & Pharmaceuticals Ltd., India’s leading Contract Development and Manufacturing Organization (CDMO), has achieved a significant regulatory milestone with the renewal of EU GMP certification for Plant 1 and the grant of EU GMP certification for Plant 2, both located in SIDCUL, Haridwar. The certifications were awarded following inspections conducted by the European Medicines Agency (EMA).
Certification Details
- Plant 1 (Renewed EU GMP):
Approved scope includes tablets, hard gelatin capsules, and powder sachets. Supported by advanced automation and robust quality systems, the facility continues to serve as a key hub for oral solid dosage forms. - Plant 2 (New EU GMP):
Certified for oral liquid dosage forms including liquids, syrups, and suspensions. Equipped with modern infrastructure and comprehensive quality control systems, the facility supports scalable manufacturing for regulated markets.
Mr. Sandeep Jain, Managing Director, Akums Drugs & Pharmaceuticals Ltd., said: “This milestone reflects years of investment in quality systems, infrastructure, and people. With EU GMP approvals for both plants, we are better positioned to serve regulated markets confidently and strengthen long‑term global partnerships.”
Mr. Sanjeev Jain, Managing Director, Akums Drugs & Pharmaceuticals Ltd., added: “EU GMP is among the most rigorous global standards. Achieving certification across two facilities simultaneously underscores our compliance maturity and operational excellence. This enhances our ability to deliver consistent quality across oral solid and liquid dosage forms.”
Strategic Impact
- Strengthens Akums’ ability to expand across Europe and other regulated geographies.
- Supports customers with a broader portfolio of high‑quality oral formulations.
- Reinforces Akums’ position as a trusted partner for global pharmaceutical companies.
- Aligns with the company’s mission to deliver safe, effective, and affordable medicines worldwide.
About Akums
Akums Drugs & Pharmaceuticals Ltd. is India’s largest CDMO, supplying a significant share of domestic pharmaceutical needs and exporting to over 65 countries. With multiple state‑of‑the‑art facilities, Akums specializes in oral solids, oral liquids, injectables, and advanced formulations. The company is committed to quality, compliance, and innovation, supporting global healthcare through reliable manufacturing partnerships.
Website: www.akums.in